Clinical Trial Update: 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating safety and efficacy of various combinations of valsartan, hydrochlorothiazide, and amlodipine in patients with modera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED